Richard M Kabaka

Richard M Kabaka

Auto-generated profile, based on publicly available information

Richard M Kabaka

National Agricultural Research Organization - NARO

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2024 in Uganda Journal of Agricultural Sciences
Verified
Journal Article
Open access
PDF file
TKTonny Kabuuka
Tonny Kabuuka
SMSamuel Mulondo
Samuel Mulondo
RERichard Ezinga
Richard Ezinga
DIDaisy Iwutung
Daisy Iwutung
RKRichard M Kabaka
Richard M Kabaka
SMSwidiq Mugerwa
Swidiq Mugerwa
In this study, a basis for the feasibility of a successful ASF vaccine design program using live attenuated vaccines was sought. One of the challenges to African swine fever (ASF) vaccine development is having a cell line that will provide commercial utility for vaccine production. We set out to address this problem by innovatively identifying possible cell lines from local domestic pigs in the country. Eight tissue types from ASF-negative animals were identified for incorporation into cell line development. These were degraded, incubated, and monitored for cell growth. One cell line, the SIR2-P, grew consistently and confluently and was tested for the ability to grow and isolate field ASF viruses. We report the isolation of ASF viruses in our laboratory for the first time. The P9C virus from Namayingo district exhibited the largest plaque sizes compared to the SQ517B virus from Mukono. The innovative identification of the SIR2-P cell line is proof of concept that newer speciesspecific cell lines can be developed in the Infectious Animal Disease Laboratory (IADL), and utilized to study other animal viruses like Porcine Reproductive and Respiratory Syndrome (PRRS) virus, Foot and mouth disease (FMD) virus, and Swine Influenza. Such cells can be used in vaccine production for other endemic diseases in Uganda. The SIR2-P cell line is currently at passage 65.